Related Experiment Video

Updated: Jun 28, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.4K

PGC-1α drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased

Grigor Varuzhanyan, Chia-Chun Chen, Jack Freeland

    Biorxiv : the Preprint Server for Biology
    |April 22, 2024
    PubMed

    Insights

    Metabolic reprogramming drives small cell neuroendocrine (SCN) cancer progression and subtype determination. PGC-1α-induced mitochondrial metabolism is a key driver, revealing new therapeutic targets for these treatment-resistant cancers.

    Area of Science:

    • Oncology
    • Metabolic pathways
    • Cancer biology

    Background:

    • Adenocarcinomas can transform into lethal, treatment-resistant small cell neuroendocrine (SCN) cancers with poorly understood metabolic profiles.
    • The influence of metabolism on SCNC subtype determination is unclear.
    • Small cell neuroendocrine cancers (SCNCs) present significant therapeutic challenges due to treatment resistance.

    Purpose of the Study:

    • To investigate the role of metabolism in driving SCNC subtype determination.
    • To identify key metabolic regulators involved in SCNC progression.
    • To explore potential metabolic vulnerabilities for therapeutic targeting in SCNCs.

    Main Methods:

    • Bioinformatic analysis of thousands of patient tumors to identify metabolic alterations.
    • Utilized a patient-derived prostate SCNC transformation system.
    • Employed cell line proliferation assays and tumor formation studies.
    • Validated findings using small-animal Positron Emission Tomography mitochondrial imaging.

    Main Results:

    • Enhanced PGC-1α, a regulator of oxidative phosphorylation (OXPHOS), was identified in various SCNCs, linked to neuroendocrine differentiation.
    • The ASCL1-expressing subtype showed elevated PGC-1α and increased OXPHOS.
    • Inhibition of PGC-1α and OXPHOS reduced SCNC proliferation and tumor formation.
    • Enhancing PGC-1α and OXPHOS increased SCNC tumor formation and promoted the ASCL1 lineage.

    Conclusions:

    • Metabolic reprogramming directly impacts cancer phenotypes in SCNCs.
    • PGC-1α-induced mitochondrial metabolism drives SCNC progression and lineage determination.
    • Identified common metabolic vulnerabilities across SCNCs from multiple tissues, suggesting pan-SCN cancer therapeutic strategies.

    More Related Videos

    Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

    Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

    Published on: May 30, 2012

    18.7K
    Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids10:26

    Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids

    Published on: October 21, 2022

    1.9K

    Related Concept Videos

    Adaptive Mechanisms in Cancer Cells02:53

    Adaptive Mechanisms in Cancer Cells

    Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
    Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
    5.7K
    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
    6.5K
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    6.3K
    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
    4.5K
    Electron Transport Chain: Complex I and II01:46

    Electron Transport Chain: Complex I and II

    The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
    ROS generation is regulated and maintained at moderate levels necessary...
    13.1K
    Cancer-Critical Genes I: Proto-oncogenes01:33

    Cancer-Critical Genes I: Proto-oncogenes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    8.8K